MLH1 and cancer: Second, while methylation data from the cancers analysed were not available, dMutLα CRCs are mostly attributed to MLH1 promoter hypermethylation as part of the CpG island methylator phenotype (CIMP), whereas this feature is not associated with MutSα inactivation [51].